In lung cancer studies [10,11,26] the majority of cancer associated somatic mutations occur in the tyrosine kinase domain of EGFR and Her-2 neu mainly in exon 18–21 and exon 19–20 respectively. Here, EGFR is linked to lung carcinoma.